| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,720 | 1,920 | 21.12. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Abound Energy Inc. Enters Into A Letter of Intent with Alluvial Capital Corp., Marking A Key Step Toward Sustainable Energy Solutions | ||
| 12.09. | Abound Energy Inc.: ABOUND Closes Second Tranche of its Unit Offering | ||
| 29.07. | Abound Energy Inc: Abound Energy appoints Chief Jones as director | ||
| 29.07. | Abound Energy Inc.: ABOUND appoints Chief Roy S. Jones Jr. to the Board of Directors to enhance Indigenous partnerships and green energy initiatives, names Doug MacDonald as Interim CEO of Zinc8 USA, and welcomes Stacey Weismiller to its Advisory Board. | ||
| 18.07. | Abound Energy Inc: Abound Energy closes $371,783 1st tranche of financing |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.08. | CalAmp Corp. - 15-12G, Securities registration termination | ||
| 01.08. | CalAmp Corp. - 8-K, Current Report | ||
| 17.07. | CalAmp Corp. - 8-K, Current Report | ||
| 28.06. | NSE - CalAmp Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Genprex schreitet in Lungenkrebs-Studie zur Phase 2 voran | ||
| Mo | Genprex advances to phase 2 in lung cancer trial | ||
| Mo | Genprex, Inc.: Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa Gene Therapy in Combination with Tecentriq in Extensive Stage Small Cell Lung Cancer | Genprex Completes Phase 1 Dose Escalation Portion of Acclaim-3 Clinical Trial
Results from Phase 1 Dose Escalation Demonstrate Favorable Safety Profile of REQORSA... ► Artikel lesen | |
| Mo | Genprex, Inc. - 8-K, Current Report | ||
| 26.11. | Genprex Signs License Deal With University Of Michigan For Lung Cancer Treatment |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 01.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 01.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 01.02.2024ISIN NameCA98959U3064 ZINC8... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ABOUND ENERGY INC | 0,025 | -5,66 % |
| CALAMP CORP | 0,089 | 0,00 % |
| GENPREX INC | 1,820 | 0,00 % |
| STATT TORSK ASA | 0,042 | -5,83 % |
